Study Links Reduced IGF1 Levels to Impaired Placental Function in Preeclampsia

A recent study published in *Biochemical Genetics* examines the role of Insulin-like Growth Factor 1 (IGF1) in pregnancies affected by preeclampsia. Researchers identified a significant drop in IGF1 levels in individuals experiencing this condition, which is characterized by high blood pressure and potential damage to organ systems after the 20th week of pregnancy. The findings suggest that reduced IGF1 levels may impact trophoblasts, specialized cells essential for placental development and function.

The study highlights the connection between IGF1 and trophoblast activity, noting that lower levels of this growth factor could interfere with normal placental processes. Trophoblasts play a critical role in nutrient exchange between mother and fetus, as well as maintaining healthy pregnancy outcomes. Preeclampsia remains a leading cause of maternal and fetal complications worldwide, making these findings relevant for understanding its underlying mechanisms. Further research may be necessary to explore how IGF1 influences placental health and its potential implications for managing preeclampsia.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 27, 2025

Related posts:

New study helps optimize gene therapy Popping Boba Gains Popularity in 2025 for Enhancing Flavor and Visual Appeal in Beverages and Desserts FDA Launches PreCheck Initiative to Streamline Approvals for US Pharmaceutical Facilities Study Explores Time Toxicity Impact on Primary Caregivers of Individuals with Schizophrenia

Author

GOAI